Gonadorelin Sublingual Tablets

Gonadorelin Sublingual Tablets

Gonadorelin

• CAS Number: 9034-40-6​
• Molar Mass: 1182.311 g·mol−1​
• Chemical Formula: C55H75N17O13​
• IUPAC Name: (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide​

Introduction

Gonadorelin Tablets are a specialized research-grade product crafted for scientific exploration and experimentation. Strictly designated for research purposes, these tablets contain Gonadorelin, a synthetic form of gonadotropin-releasing hormone (GnRH), recognized for its potential therapeutic applications. ​

Key Characteristics

Gonadorelin Tablets are characterized by the inclusion of highly purified Gonadorelin, ensuring the precision and reliability of research findings. Formulated for enduring stability under appropriate storage conditions, these tablets maintain their integrity over time. Each tablet is precisely dosed, facilitating consistent and accurate research outcomes.​

Research Applications

Gonadorelin Tablets find application in diverse research areas, with a primary focus on unraveling the molecular mechanisms and potential therapeutic benefits associated with GnRH and its analogs.​

Research Benefits

• Gonadorelin and Breast Cancer

  Exploratory studies suggest a potential link between Gonadorelin and breast cancer. Research in this area investigates the hormone’s impact on breast cancer cells, aiming to provide insights into novel therapeutic approaches or preventive strategies.​

• Gonadorelin and Male Infertility

  Gonadorelin’s role in addressing male infertility is a subject of research interest. Studies indicate its potential to stimulate the production of reproductive hormones, offering possibilities for understanding and addressing male reproductive challenges. ​

• Gonadorelin and Dementia

  Research examining the relationship between Gonadorelin and dementia explores the hormone’s neuroprotective effects. Preliminary studies suggest a potential connection, prompting further investigations into the therapeutic implications for cognitive function and neurodegenerative disorders.​

Summary

In summary, Gonadorelin Tablets serve as a valuable tool for researchers delving into the multifaceted benefits of Gonadorelin. From exploring its potential impact on breast cancer cells to investigating its role in addressing male infertility and potential connections to dementia, these tablets offer a platform for advancing knowledge in critical research areas. It is imperative to emphasize that this product is exclusively intended for research purposes and is not intended for human consumption.​

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.​

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).​

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.​

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at support@bc9.co.​

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.​

References

• Secreto G, Sieri S, Agnoli C, Grioni S, Muti P, Zumoff B, Sant M, Meneghini E, Krogh V. A novel approach to breast cancer prevention: reducing excessive ovarian androgen production in elderly women. Breast Cancer Res Treat. 2016 Aug;158(3):553-61. doi: 10.1007/s10549-016-3901-1. Epub 2016 Jul 9. PMID: 27393623.​

• Rajkanna J, Tariq S, Oyibo SO. Successful fertility treatment with gonadotrophin therapy for male hypogonadotrophic hypogonadism. Endocrinol Diabetes Metab Case Rep. 2016;2016:150124. doi: 10.1530/EDM-15-0124. Epub 2016 Jan 7. PMID: 26807263; PMCID: PMC4722247.​

• Meethal SV, Smith MA, Bowen RL, Atwood CS. The gonadotropin connection in Alzheimer’s disease. Endocrine. 2005 Apr;26(3):317-26. doi: 10.1385/ENDO:26:3:317. PMID: 16034187.